Page last updated: 2024-08-23

phosphotyrosine and pd 173955

phosphotyrosine has been researched along with pd 173955 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdullah, OM; Bohacek, RS; Clackson, T; Dalgarno, D; Deininger, MW; Druker, BJ; Keats, JA; Metcalf, CA; Moseson, EM; O'Hare, T; Pollock, R; Rivera, VM; Sawyer, TK; Shakespeare, WC; Stoffregen, EP; Sundaramoorthi, R; Tang, H; Wang, Y1

Other Studies

1 other study(ies) available for phosphotyrosine and pd 173955

ArticleYear
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
    Blood, 2004, Oct-15, Volume: 104, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Amino Acids; Apoptosis; Benzamides; Cell Cycle; Cell Division; DNA-Binding Proteins; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Imatinib Mesylate; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Milk Proteins; Models, Molecular; Mutation; Nuclear Proteins; Phosphorylation; Phosphotyrosine; Piperazines; Protein Structure, Tertiary; Pyridones; Pyrimidines; STAT5 Transcription Factor; Trans-Activators

2004